Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome
<p>Abstract</p> <p>Background</p> <p>Multiple Endocrine Neoplasia type 1 (MEN1, OMIM 131100) is an autosomal dominant disorder characterized by endocrine tumors of the parathyroids, pancreatic islets and pituitary. The disease is caused by the functional loss of the tum...
Main Authors: | Laramie Jason M, Cobb J Perren, Verma Sulekha, Kalyanaraman Somasundaram, Dilley William G, Lairmore Terry C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-02-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/4/1/9 |
Similar Items
-
CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
by: Sebastian Krug, et al.
Published: (2020-07-01) -
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas
by: Terry C. Lairmore, et al.
Published: (2023-02-01) -
Pilot Study: FSHR Expression in Neuroendocrine Tumors of the Appendix
by: Dariusz Starzyński, et al.
Published: (2023-08-01) -
CK19 and CD99 immunoexpression profile in goblet cell (mucin-producing neuroendocrine tumors) and classical carcinoids of the vermiform appendix.
by: Alsaad, K, et al.
Published: (2007) -
Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
by: Andreas Selberherr, et al.
Published: (2019-02-01)